Akso Health Group
Income Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Revenue | $107.3M | $22.9M |
| Cost of Revenue | $8.5M | $5.1M |
| Gross Profit | $107.3M | $22.9M |
| Gross Margin | 100.0% | 100.0% |
| Operating Expenses | ||
| Research & Development | $2.8M | $1.6M |
| SG&A Expense | $5.8M | $2.6M |
| Operating Income | $75.9M | $9.9M |
| Operating Margin | 70.7% | 43.3% |
| Interest Expense | — | — |
| Pretax Income | $76.5M | $10.1M |
| Income Tax Expense | $11.0M | $1.5M |
| Net Income | $65.5M | $8.6M |
| Net Margin | 61.1% | 37.4% |
| EPS (Basic) | $0.04 | $0.01 |
| EPS (Diluted) | $0.04 | $0.01 |
| Shares Outstanding (Basic) | 1.62B | 1.52B |
| Shares Outstanding (Diluted) | 1.72B | 1.52B |
| Dividends Per Share | — | — |